Last updated: February 19, 2021
Sponsor: I.M. Sechenov First Moscow State Medical University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Bladder Cancer
Urothelial Cancer
Urothelial Carcinoma
Treatment
N/AClinical Study ID
NCT04750590
ERBT -MORC20
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients scheduled for endoscopic bladder tumor removal
- Non-muscle invasive bladder cancer on contrast-enhanced MRI or CT (stage cT1N0M0 andlower)
- Diameter of tumor >3cm
Exclusion
Exclusion Criteria:
- Patient refused to participate in the trial
- Multiple (more than 2) bladder tumors
- Previous cold-cup biopsy or any other surgery for bladder tumor
- Muscle-invasive bladder cancer on postoperative histological evaluation
- Other malignant/benign tumors of the bladder (non-urothelial cancer)
Study Design
Total Participants: 180
Study Start date:
January 11, 2021
Estimated Completion Date:
June 11, 2022
Connect with a study center
Institute for Urology and Reproductive Health, Sechenov University.
Moscow, 119991
Russian FederationActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.